Research
    Li An Hua
    Title Professor and director of department
    Profile

    Dr. Li An Hua is professor and director of the ultrasound department in Sun Yat-sen University Cancer Center. Dr. Li obtained her Bachelor in Medicine in China in 1982 and MSc degree in England in 2001. She acts as a express into Sun Yat-sen University in 2003, From that, she is working on ultrasound diagnosis and interventional treatment of tumors. 

    In clinical practice, she focus on diagnosis those lesions exactly of breast, thyroid, liver, lymph node and so on. Include image guide biopsy. In clinical research practice, she interest in contrast imaging with ultrasound contrast agent and quantification analysis with perfusion imaging of tumor. In department manage practice, she pay attention to help young doctors and new technology of imaging into clinical practice. Dr.Li has published more than 90 research papers..

    Email liah@sysucc.org.cn
    Phone 0086-20-87343211
    Research Interest(s)
    Education
    Publications

    1. Zhou JH , Cao LH ,Zheng W, Liu M, Han F, Li AHContrast-Enhanced Gray-Scale Ultrasound for Quantitative Evaluation of Tumor Response to Chemotherapy: Preliminary Results With a Mouse Hepatoma Model AJR: 196,January 2011 13-17 (Americal Journal of Roentgenoloy)

    2.Zhou JH ,Zheng W, Cao LH, Liu M, Luo RZ, Han f, Wu PH. Li AHOuantitative evaluation of viable tissue perfusion changes with congtrast-enhanced grayscale ultrasound in s mouse hepatoma model following treatment with different doses of thalidomide. Br J Radiol 2011 Jan 11 [Epub ahead of print]

    3. Xiao Qing Pei, Long Zhong Liu, Wei Zheng, , Mu Yan Cai, Feng Han, Jie Hua He, An Hua Li, and Min Shan Chen, Contrast-enhanced ultrasonography of hepatocellular carcinoma: Correlation between quantitative parameters and arteries in neoangiogenesis or sinusoidal capillarization European Journal Radiology ,23 Feb 2011

    4 Lin X, Wang J, Han F, Fu J, Li AH.Analysis of eighty-one cases with breast lesions using automated breast volume scanner and comparison with handheld ultrasound. Eur J Radiol. 2011 Mar 18. [Epub ahead of print]

    5. Zhou JH ,Zheng W, Cao LH, Liu M, Luo RZ, Han f, Wu PH. Li AH Quantitative Assessment of Tumor Blood Flow in Mice after Treatemnt with Different Doses of an Antiangiogenic Agent with Contrast-enhanced Destraction-Replenishment US.. Raiology 2011 Vol 259.Num 2 406-413

    6. Zhou JH ,Zheng W, Cao LH, Liu M, Luo RZ, Han f, Wu PH. Li AHContrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment.Eur J radiology2011 Feb21,[Epub ahead of print]

    7 .Jianhua Zhou Wei Zheng Anhua Li et al: Antiangiogenic Tumor Treatment :Noninvasive Monitoring with Contrast Pulse Sequence Imaging for Contrast-Enhanced Grayscale Ultrasound. Academic Radiology, 2010,17(5):646-51

    8. J H ZHOU, MD, 1A H LI, MD,Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound,The British Journal of Radiology, 81 (2008), 113–119 

    9. Ming-de Lu, Xiao-ling Yu, An-hua Li, et al.(Multiple center clinical trail of China)Comparison of Contrast Enhanced Ultrasound and Contrast Enhanced CT or MRI in Monitoring Percutaneous Thermal Ablation Procedure in Patients with Hepatocellular Carcinoma: A Multi-Center Study in ChinaUltrasound in Medicine & Biology, Volume 33, Issue 11, November 2007, 1736-174

    Books

    1. Li Anhua. Echocaidiography. Medical Imaging and Clinical, Feng gansheng, (Editor), The Hubei Science and Technology Press., 1994.

    2. Li Anhua, Ocular sonography in children. Children Ultrasonic Diagnosis. Xia Bei (Editor), The Peoper’s Health Press, 20003. Li Anhua (Editor) , Breast ultrasonography, The Peoper’s Health Press (furture). 2004


    Last Updated on: 2011

    Zhou Jianhua
    Title Associate chief physician, advisor of master's degree student, Deputy Director of Ultrasound and Electrocardiogram
    Profile

    Born in September 1977, Dr. Zhou Jianhua has been working in the Ultrasound Diagnosis and Interventional Treatment at Sun Yat-sen University Cancer Center since he graduated from undergraduate program from former Sun Yat-sen University of Medical Sciences in 2001. He was conferred upon the degree of Master of Clinical Medicine in 2005 and the degree of Doctor of Medicine in 2009 by Sun Yat-sen University. He furthered his studies at Thomas Jefferson University Hospital in the U.S. between September 2009 and August 2010, under the instruction of Professor Barry. B Goldberg, former president of the World Federation for Ultrasound in Medicine and Biology (WFUMB) and Professor Liu Jibin, participating in several pieces of research work and clinical work about ultrasonic contrast.

    In 2009, he won the first Youth Talent Training Program of Sun Yat-sen University Cancer Center and in 2012, obtained support from the Guangzhou Pearl River Science & Technology Rising Star Project. He was elected to the Program for New Century Excellent Talents in University run by the Ministry of Education in 2013 and as a school-level trainee, the Hundred, Thousand, and Ten Thousand Talents Project of Guangdong Higher Education in 2012. He is now an associate chief physician in Ultrasound Diagnosis and Interventional Treatment, engaging himself in ultrasound diagnosis and interventional treatment of cancer. He specializes in ultrasound diagnosis and interventional treatment of such cancer as hepatobiliary cancer, urinary system cancer, breast cancer, thyroid cancer and lymphoma, with considerable experience of in-depth research into diagnosis of liver tumors by ultrasonic contrast and evaluation of its therapeutic effects.

    Work experience
    07/2001-12/2006 Physician, Sun Yat-sen University Cancer Center

    01/2007-12/2010 Attending physician, Sun Yat-sen University Cancer Center

    01/2011-present Associate chief physician, Sun Yat-sen University Cancer Center

    Email
    Phone
    Research Interest(s)
    Education

    09/1996-06/2001 Undergraduate, former Sun Yat-sen University of Medical Sciences

    09/2001-12/2005 Master's degree student, Sun Yat-sen University

    09/2006-06/2009 Doctoral student, Sun Yat-sen University

    09/2009-08/2010 Thomas Jefferson University

    Publications
    Lin Xi
    Title Associate chief physician
    Profile

    Born in December 1978, Dr. Lin Xi has been working in the Ultrasound Diagnosis and Interventional Treatment at Sun Yat-sen University Cancer Center since she graduated from undergraduate program from Sun Yat-sen University in 2002. She was conferred upon the degree of Master of Clinical Medicine in 2008 and the degree of Doctor of Clinical Medicine in 2011 by Sun Yat-sen University. She furthered her studies in Breast Screening and Diagnostic Imaging Centre at University of Western Australia between September 2010 and September 2011. She has been an associate chief physician in Ultrasound Diagnosis and Interventional Treatment since January 2013, engaging herself in ultrasound diagnosis and interventional treatment of cancer. She specializes in ultrasound diagnosis and interventional treatment of such cancer as hepatobiliary cancer, urinary system cancer, breast cancer, thyroid cancer, lymphoma and gynecological cancers, with considerable experience of in-depth research into early diagnosis of breast cancer and other superficial organ tumors.

    Email linxi@sysucc.org.cn
    Phone
    Research Interest(s)

    Radiology; breast cancer

    Education

    She graduated from undergraduate program from Zhongshan School of Medicine, Sun Yat-sen University in 2002, and was conferred upon the degree of Master of Clinical Medicine in 2008 and the degree of Doctor of Clinical Medicine in 2011 by Sun Yat-sen University.

    Publications

    1. Analysis of eighty-one cases with breast lesions using automated breast volume scanner and comparison with handheld ultrasound. Lin X, Wang J, Han F, Fu J, Li A. Eur J Radiol. 2012 May;81(5):873-8. (lead author)

    2. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through upregulation of FOXO3a. Lin C, Wu Z, Lin X, Yu C, Shi T, Zeng Y, Wang X, Li J, Song L. Clin Cancer Res. 2011 May 15;17(10):3089-99. (co-lead author)

    3. Short term results of neoadjuvant chemoradiotherapy with fluoropyrimidine alone or in combination with oxaliplatin in locally advanced rectal cancer: a meta analysis. An X, Lin X, Wang FH, Goodman K, Cai PQ, Kong LH, Fang YJ, Gao YH, Lin JZ, Wan DS, Pan ZZ, Ding PR. Eur J Cancer. 2013 Mar;49(4):843-51 (co-lead author)

    4. Quantitative assessment of spinal cord perfusion by using contrast-enhanced ultrasound in a porcine model with acute spinal cord contusion. Huang L, Lin X, Tang Y, Yang R, Li AH, Ye JC, Chen K, Wang P, Shen HY. Spinal Cord. 2013 Mar;51(3):196-201. (co-lead author)

    5. Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells. Chen X, Ying Z, Lin X, Lin H, Wu J, Li M, Song L. J Clin Invest. 2013 Jun 3;123(6):2576-89

    6. Nkx2-8 downregulation promotes angiogenesis and activates NF-κB in esophageal cancer. Lin C, Song L, Gong H, Liu A, Lin X, Wu J, Li M, Li J. Cancer Res. 2013 Jun 15;73(12):3638-48.

    7. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Huang L, Dai T, Lin X, Zhao X, Chen X, Wang C, Li X, Shen H, Wang X. Biochem Biophys Res Commun. 2012 Aug 24;425(2):127-33


    Last Updated on: 2013

    Zhang Liyuan
    Title Associate chief technician
    Profile

    Dr. Zhang Liyuan, the associate chief technician, engages in ECG diagnosis in Department of Ultrasound Diagnosis and Interventional Treatment, Sun Yat-sen University Cancer Center. Originally, she worked in Sun Yat-sen Memorial Hospital, SYSU, for the Department of Internal Medicine in 1984 and for the Electrocardiographic Room in 1987. She was exceptionally promoted as technician in charge in 1998 by virtue of her excellent work performances and remarkable scientific researches.

    In 1999, as the ECG technical backbone, she was transferred to Department of Ultrasound Diagnosis and Interventional Treatment in Sun Yat-sen University Cancer Center to work on ECG technology, strengthen the technical strength of the Electrocardiographic Room and lead the young doctors to improve their skills in ECG diagnosis and abilities in arhythmia diagnosis & differential diagnosis. She has obtained the Medical Practitioner's Qualification Certificate and been devoted to ECG diagnosis all the years.

    In 2011, she became an associate chief technician. Through her 27-year ECG technological profession, she has accumulated abundant work experience, acquired solid theoretical knowledge, been steadily proficient in ECG diagnosis reports, been adept at complex arhythmia diagnosis and differentiation, tackled a variety of difficult problems independently and played a backbone role in the Electrocardiographic Room. During her career life, she has published over 30 papers as lead author on public medical journals and core professional journals and undertaken one program funded by National Natural Science Foundation of China, one project of Guangdong Provincial Natural Science Foundation and projects of Guangdong Provincial Department of Health. On April 8, 2011, she attended the 13th South China International Congress of Cardiology and gave a lecture on The Common ECG Expressions of Myocardial Damage of Chemotherapy Drugs.

    Email zhangly@sysucc.org.cn
    Phone 020-87343213
    Research Interest(s) ECG Technology
    Education

    09/1981-07/1984 Studied in Health School of former Zhongshan Medicine School

    09/2002-07/2006 Majored in Medical Imaging, School of Continuing Education, SYSU

    03/2007-2010 Majored in Clinical Medicine in School of Continuing Education, SYSU and received the Bachelor’s Degree in Clinical Medicine

    Publications

    1. 12/2012 100 Case clinical analysis of QRS wave voltage reduction for patients with malignant tumor during chemotherapy. Lingnan Journal of Emergency Medicine

    2. 2011 Occurrence of arrhythmia in patients with esophageal cancer during combined treatment. International Medicine and Health Guidance News, Issue 23

    3. 08/2011 Analysis of combined electrocardiographic QRS alternans in malignant tumor patients. Chinese Journal of Prevention and Control of Chronic Diseases

    4. 06/2011 Clinical analysis of the arrhythmia of 300 patients with nasopharyngeal carcinoma. Lingnan Journal of Emergency Medicine

    5. 10/2010 Changes of ECG during chemotherapy in patients with malignant tumor. Chinese Journal of Cardiac Pacing and Electrophysiology

    6. 08/2010 Study on the change of ECG after chemotherapy and radiotherapy in treatment of patients with breast cancer. Chinese Journal of Primary Medicine and Pharmacy

    7. 08/2010 Clinical analysis of the arrhythmia of 1000 patients with malignant tumor. Lingnan Journal of Emergency Medicine

    8. 01/2008 Clinical analysis of 500 cases of malignant tumor complicated with ECG low voltage. Guangdong Medical Journal

    9. 08/2006 Analysis of electrocardiogram of 1000 patients with malignant tumors during the treatment period. Lingnan Journal of Emergency Medicine

    9. 10/2004 Electrocardiogram expressions caused by some tumors. Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease

    10. 03/2003 Analysis of ECG in patients with lung cancer during the treatment. Chinese New Medicine

    11. 08/2001 Analysis of electrocardiogram in 120 patients with breast cancer chemotherapy. The Journal of Practical Medicine

    12. 05/2000 Analysis of acute myocardial infarction and ventricular arrhythmia. Journal of Clinical Eletrocardiology

    13. 11/1999 Analysis of ECG in 316 cases of middle-aged and elderly patients. Journal of Practical Electrocardiology

    14. 09/1999 Development of heart rate variability computer system. Modern Medical Equipment and Application

    15. 05/1999 ECG ST-segment elevation and ST-T normalization of myocardial ischemia induced by exercise test. Journal of Clinical Eletrocardiology

    16. 1990-1998 More than ten published papers


    Last Updated on: 2012

    Xiao-Qing Pei
    Title Deputy Chief Physician
    Profile
    Dr. Xiao-qing Pei obtained her Bachelor in Medicine (equivalent to MD in the US) and PhD at Sun Yat-sen University of Medical Sciences, P. R. China in 2001 and 2010, respectively.
    Email peixq@sysucc.org.cn
    Phone +862087343212
    Research Interest(s)

    Ultrasound evaluation of the effect of cancer chemotherapy, shear wave elastography (shear wave elasticity imaging), ultrasound imaging (contrast-enhanced ultrasonography) diagnostic and research work 

    Sponsored research projects funded: 

    1. VEGFR2-targeted ultrasound contrast experimental study in mice quantitative analysis and evaluation of anti-tumor treatment of pancreatic cancer (National Natural Science Foundation, project approval number: 81201103, 2013.1-2015.12) 

    2 CEUS quantitative analysis of cervical cancer and its role in the effect of neoadjuvant chemotherapy to determine the (Guangdong Province Medical Research Foundation, Project Grant No.: B2011116,2012.1-2013.12) 

    3 Quantitative ultrasound imaging studies in cancer neoadjuvant chemotherapy application (center study start fund 2013-4)

    Education

    2011.8-2012.7, England St Thomas' Hospital (School of Medicine, King's College London) (St. Thomas • King's College London) Visiting Scholar 

    2007.9-2010.6 Dr. Sun Yat-sen Graduate. 

    2001.9-2005.12 Sun Yat-sen Graduate 

    1996.9-2001.6 Zhongshan Medical University undergraduate

    Publications

    (1) Pei XQ, Liu LZ, Xiong YH, Zou RH, Chen MS, Li AH, Cai MY. Quantitative analysis of contrast-enhanced ultrasonography: differentiating focal nodular hyperplasia from hepatocellular carcinoma. Br J Radiol, 2013 Epub 2013 Feb 7.

    (2) Pei XQ, Liu LZ, Zheng W, Mu Yan Cai, Feng Han, Jie Hua He, An Hua Li, Min Shan Chen. Contrast-enhanced ultrasonography of hepatocellular carcinoma: Correlation between quantitative parameters and arteries in neoangiogenesis or sinusoidal capillarization. Eur J Radiol,2012; 81:e182-e188. 

    (3) Pei XQ, Liu LZ, Liu M, Zheng W, Han F, Li AH. Contrast-enhanced ultrasonography of hepatocellular carcinoma: correlation between quantitative parameters and histologic grading. Br J Radiol,2012 Sep; 85(1017):e740-7.

    (4) Cai MY, Luo RZ, Chen JW, Pei XQ, Lu JB, Hou JH, Yun JP. Overexpression of ZEB2 in peritumoral liver tissue correlates with favorable survival after curative resection of hepatocellular carcinoma.. PLoS One. 2012;7(2):e328-38

    (5) Pei XQ, Liu LZ, ZhengW, et al. Contrast-enhanced Ultrasonography of Hepatocellular Carcinoma: correlation between quantitative parameters and arteries in neoangiogenesis. Chin J Ultrasonogr, 2011, 20(3):222-225.

    (6) Pei XQ, Chen MS, Liu LZ,et al. Study on Dynamic vascular curve f(t) of contrast-enhanced ultrasound in differential diagnosis hepatocellular carcinoma from focal nodular hyperplasia. Chin J Ultrasound Med. 2010, 6(5): 444-448.

    (7) Pei XQ, Liu LZ, Li JY,et al. Misdiagnosis Analysis of Contrast-enhanced Ultrasonography for Focal Liver Lesions. Chin J Ultrasonogr, 2010,19(4):314-316.

    (8) Pei XQ, Liu LZ,Liu M,et al. Effect of cirrhosic liver on dynamic vascular curves analysis of hepatocellular carcinomas at contrast-enhanced ultrasound. Chin J Ultrasonogr.Chin J Ultrasonogr, 2010,19(7): 576-579.

     

    Last Updated on: 2013

Where are we | Contact us|

Copyright:Sun Yat-sen University Cancer Center Designed by Wanhu.